IL6 and chronic myelogenous leukemia, BCR-ABL1 positive: Acute neurotoxicity and paralysis in hyperlipidemic zebrafish by CML administration (final 6 mM) were also protected by the co-presence of CIGB-258 via inhibition of hepatic inflammation and IL-6 production (Figure 6, Figure 7, Figure 8, Figure 9, Figure 10, Figure 11, Figure 12 and Figure 13).